ConductScience.org, home

Comparison · NCT00418457-1ec6fdd3

General Anesthesia and Opioid vs Regional Analgesia and Propofol: Number of Participants Who Had Breast Cancer Recurrence After Breast Cancer Surgery

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. General Anesthesia and Opioid vs Regional Analgesia and Propofol: Number of Participants Who Had Breast Cancer Recurrence After Breast Cancer Surgery. Trial comparisons, record NCT00418457-1ec6fdd3. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00418457-1ec6fdd3

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.1040.08730.124wilson
Risk in group 20.09780.08120.117wilson
Risk difference, group 1 minus group 20.00643-0.01940.0323newcombe hybrid score
Risk ratio, group 1 over group 21.070.8261.38log
Odds ratio, group 1 over group 21.070.8081.43log
Number needed to treat, for one more participant with the outcome on General Anesthesia and Opioid than on Regional Analgesia and Propofol156from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1General Anesthesia and OpioidGeneral anesthesia followed by opioid administration~General anesthesia and opioids: General anesthesia, usually with sevoflurane, and opioid analgesia1111,065OG000
Group 2Regional Analgesia and Propofol
Regional anesthesia and analgesia (either epidural or paravertebral) combined with propofol~Regional analgesia and propofol: Regional anesthesia and analgesia (either epidural or paravertebral), combined with deep sedation or general anesthesia
1021,043OG001

Outcome

Type
PRIMARY
Title
Number of Participants Who Had Breast Cancer Recurrence After Breast Cancer Surgery
Description
time to breast cancer recurrence from the end of surgery.
Time frame
up to 10 years
Population

Source ClinicalTrials.gov

Trial

Title
Regional Anesthesia and Breast Cancer Recurrence
NCT number
NCT00418457
Phases
PHASE3
Conditions
Breast Neoplasms
Interventions
General anesthesia and opioids, Regional analgesia and propofol
Lead sponsor
The Cleveland Clinic
Results first posted
2020-06-16

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT00418457-1ec6fdd3